Long QT Syndrome

Researchers identified a small molecule that improves the localization of a potassium channel frequently mislocalized and impaired in the genetic heart rhythm disorder known as long QT syndrome. The study provides proof of principle that future therapies aimed at correcting the underlying molecular defect in this potentially fatal genetic disorder could be viable. Read More